Under what circumstances can the Ministry issue a marketing authorization for a pharmaceutical equivalent?
The Ministry can issue a marketing authorization for a pharmaceutical equivalent if it is biologically and specifically equivalent to a pharmaceutical product whose legal protection has been removed, and a marketing authorization has been issued for it in accordance with the provisions of the Federal Law No. 17 of 2002 and international agreements to which the State is a party.